Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025
Endocrine Journal · 2026 · 73 (1) · 115-157
DOI: 10.1507/endocrj.ej25-0165 ↗Kurz gefasst
Leitlinie in der Zeitschrift Endocrine Journal, 2026. Verfasst von Akiyo Tanabe und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Hospital; Director, Endocrinology and Adrenal Tu…. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Endocrinology. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Center for Global Health and Medicine, Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Hospital; Director, Endocrinology and Adrenal Tumor Center, Tokyo 162-8655, Japan.
- Department of Metabolism and Endocrinology, St. Marianna University Yokohama Seibu Hospital, Yokohama 226-0015, Japan.
- Department of Endocrinology, Metabolism, Diabetology and Nephrology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu 969-3492, Japan.
- Division of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago 683-8504, Japan.
- Department of Diabetes and Endocrinology, Saiseikai Yokohamashi Tobu Hospital, Yokohama 230-8765, Japan.
- Department of Endocrinology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Förderung
- National Center for Global Health and Medicine
- Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
Zitieren
APA
Tanabe, A., Katabami, T., Hashimoto, S., Izawa, S., Ichijo, T., Otsuki, M., Oriuchi, N., Kinuya, S., Kinoshita, H., Kimura, N., Shibata, H., Sone, M., Takahashi, K., Takizawa, N., Takekoshi, K., Tsuiki, M., Tanase-Nakao, K., Nakamura, Y., Nishimoto, K., …, & Naruse, M. (2026). Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025. Endocrine Journal, 73(1), 115-157. https://doi.org/10.1507/endocrj.ej25-0165
Vancouver
Tanabe A, Katabami T, Hashimoto S, Izawa S, Ichijo T, Otsuki M, et al. Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025. Endocrine Journal. 2026;73(1):115-157. doi:10.1507/endocrj.ej25-0165
BibTeX
@article{Tanabe2026,
author = {Tanabe, Akiyo and Katabami, Takuyuki and Hashimoto, Shigeatsu and Izawa, Shoichiro and Ichijo, Takamasa and Otsuki, Michio and Oriuchi, Noboru and Kinuya, Seigo and Kinoshita, Hidefumi and Kimura, Noriko and Shibata, Hirotaka and Sone, Masakatsu and Takahashi, Katsutoshi and Takizawa, Nae and Takekoshi, Kazuhiro and Tsuiki, Mika and Tanase-Nakao, Kanako and Nakamura, Yasuhiro and Nishimoto, Koshiro and Hasegawa, Tomonobu and Murakami, Masanori and Yonamine, Masato and Naruse, Mitsuhide},
title = {Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025},
journal = {Endocrine Journal},
year = {2026},
volume = {73},
number = {1},
pages = {115--157},
doi = {10.1507/endocrj.ej25-0165}
}
EUVIMED